Trace amine-associated receptor

From WikiMD's WELLNESSPEDIA

Trace amine-associated receptor (TAAR) is a family of G protein-coupled receptors that are predominantly expressed in the olfactory epithelium. They were discovered in 2001 and are named for their ability to bind trace amines, which are present in the body in trace amounts.

Function[edit]

TAARs are involved in a variety of physiological processes. They are known to play a role in the regulation of neurotransmitter release, neuroendocrine function, and immune system response. Some TAARs are also thought to be involved in the detection of social cues through the olfactory system.

Classification[edit]

There are nine known human TAARs, which are classified into two groups: Class I and Class II. Class I TAARs are closely related to amine receptors, while Class II TAARs are more closely related to peptide receptors.

Ligands[edit]

TAARs are activated by a variety of ligands, including trace amines, amines, and peptides. Some TAARs are also activated by volatile compounds, which are thought to be important for the detection of social cues.

Clinical significance[edit]

Alterations in TAAR function have been implicated in a variety of diseases, including psychiatric disorders, neurodegenerative diseases, and cancer. As such, TAARs are considered potential targets for the development of new therapeutic agents.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.